Analytical Data
-
基因名
Fam111a
- Application
-
别名
Fam111a; Kiaa1895; Protein FAM111A
-
种属
Mouse
-
表达系统
Yeast
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9D2L9
-
表达区间
1-613aa
-
分子量
71.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fam111a (Family with Sequence Similarity 111 Member A) is a protein that has garnered attention due to its potential roles in cellular processes and implications in human diseases. Research has shown that Fam111a may be involved in DNA damage response, cell cycle regulation, and chromatin remodeling, highlighting its significance in maintaining genomic stability. Mutations in the Fam111a gene have been linked to genetic disorders, including certain cancers and developmental abnormalities, making it a target of interest for molecular biology and medical research. The study of recombinant Fam111a protein is crucial for understanding its structure-function relationships and exploring its mechanistic roles in cellular pathways. By producing and characterizing this protein in vitro, researchers aim to elucidate the molecular interactions and regulatory mechanisms in which Fam111a participates. Furthermore, recombinant techniques provide a platform for developing potential therapeutic strategies that could mitigate the effects of defects associated with Fam111a dysfunction. Overall, the exploration of Fam111a and its recombinant forms is pivotal for advancing our knowledge of cellular biology and has the potential to inform the development of targeted therapies for related diseases.
